logo
Share SHARE
FONT-SIZE Plus   Neg

Oramed'PlatformTech In Oral Delivery Of Proteins Gets Patent In Israel,Australia

Oramed Pharmaceuticals Inc. (ORMP), a developer of oral drug delivery systems, announced Thursday that it has received Notices of Allowance from the Israel and Australian Patent Offices.

The patent entitled, "Methods and Compositions for Oral Administrations of Proteins" covers a core concept of the company's technology for the oral delivery of drugs and vaccines currently delivered via injection.

The company stated that the allowance in Israel marks the second from the Israel Patent Office in the past 30 days. Additionally, this is Oramed's second Australian patent allowance, following the grant of a different patent in May 2012.

The company noted that the patent has also been approved in Japan, China, Russia, and New Zealand.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Media conglomerate Viacom, Inc. on Tuesday reported a 10 percent decline in profit for the first quarter from last year, reflecting lower revenues in the Filmed Entertainment and Media Networks segments. However, adjusted earnings per share for the quarter matched analysts' expectations, while revenues missed their estimates. Google chief Sundar Pichai is poised to become the highest-paid chief executive in the U.S. after parent company Alphabet awarded him $199 million in shares. Alphabet Inc. (GOOGL, GOOG) disclosed in a regulatory filing with the U. S. Securities and Exchange Commission that it awarded 273,328 shares worth $199 million to Pichai on February 3rd. Transmission utility ITC Holdings Corp. announced Tuesday that it has entered into an agreement and plan of merger to be acquired by Canadian electric and gas utility company Fortis Inc. in a deal valued at approximately $11.3 billion. ITC shareholders will receive $22.57 in cash and 0.7520 Fortis shares per ITC share.
comments powered by Disqus
Follow RTT